Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

There is no fulltext present in this item.

Title:	Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
Author(s):	Noordman, B.J.; Spaander, M.C.W.; Valkema, R.; Wijnhoven, B.P.; Berge Henegouwen, M.I. van; Shapiro, J.; Siersema, P.D. ; Janssen, M.J.R. ; Post, R.S. van der; Radema, S.A. ; Rosman, C. ; Rütten, H.; Lanschot, J.J. van; Steyerberg, E.W.
Publication year:	2018
Source:	Lancet Oncology, vol. 19, iss. 7, (2018), pp. 965-974
ISSN:	1470-2045
DOI:	https://doi.org/10.1016/S1470-2045(18)30201-8
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/194346
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 14: Tumours of the digestive tract RIHS: Radboud Institute for Health Sciences Radboudumc 14: Tumours of the digestive tract RIMLS: Radboud Institute for Molecular Life Sciences Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences
Organization:	Gastroenterology Medical Imaging Pathology Medical Oncology Surgery Radiation Oncology
Journal title:	Lancet Oncology
Volume:	vol. 19
Issue:	iss. 7
Page start:	p. 965
Page end:	p. 974